July 2010 In the last few months, three biotech IPO's were added bringing the total of biotch IPO's since last August to 23. Genmark Diagnostics (US), CorMedix (US), and Novagali (France) each raised under USD$30M, which is under the median amount raised for all 23 biotech IPOs – globally (USD$39M) and in the US (USD$79M) . The post IPO performance continues to be weak, with the median stock performance down over 20%. The table below was sourced from Inside Bio http://insidebioia.com.